SCHEMBL14985108

SCHEMBL14985108

CN(C)c1ccc(NC(=O)NCc2ccc(CNCCCN(O)C(=O)/C=C/C(=O)O)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM6B O15054 2/20 0.58
KDM4A O75164 2/20 0.58
KDM2A Q9Y2K7 1/20 0.58
KDM4E B2RXH2 1/20 0.49
EGLN2 Q96KS0 1/20 0.49
EGLN1 Q9GZT9 1/20 0.49
KDM4C Q9H3R0 1/20 0.49
EGLN3 Q9H6Z9 1/20 0.49
HIF1AN Q9NWT6 1/20 0.49
PHF8 Q9UPP1 1/20 0.49
NAMPT P43490 3/20 0.47
NR4A1 P22736 1/20 0.46
CNR1 P21554 1/20 0.45
F7 P08709 1/20 0.45
HDAC1 Q13547 9/20 0.43
HDAC2 Q92769 9/20 0.43
HDAC10 Q969S8 9/20 0.43
HDAC8 Q9BY41 9/20 0.43
HDAC6 Q9UBN7 9/20 0.43
HDAC3 O15379 8/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14981983 0.88 KDM6B (0.46) KDM6BKDM4AKDM2AKDM4EEGLN2
SCHEMBL14985104 0.87 KDM4E (0.61) KDM6BKDM4AKDM2AKDM4EEGLN2
SCHEMBL14985125 0.84 KDM4E (0.65) KDM6BKDM4AKDM2AKDM4EEGLN2
SCHEMBL14985131 0.77 KDM4E (0.50) KDM6BKDM4AKDM2AKDM4EEGLN2
SCHEMBL14981982 0.77 NAMPT (0.42) NAMPTCNR1F7HDAC1HDAC2
SCHEMBL14985124 0.76 KDM4E (0.55) KDM6BKDM4AKDM2AKDM4EEGLN2
SCHEMBL14985161 0.75 KDM6B (0.80) KDM6BKDM4AKDM2AKDM4EEGLN2
SCHEMBL14981985 0.74 KDM6B (1.00) KDM6BKDM4AKDM2AKDM4EEGLN2
SCHEMBL14985128 0.74 KDM6B (0.70) KDM6BKDM4AKDM2AKDM4EEGLN2
SCHEMBL14981979 0.72 KDM4E (0.47) KDM6BKDM4AKDM2AKDM4EEGLN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735622-B2 Histone demethylase inhibitors and methods for using the same THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2014-05-27 US disclosed
US-20130137720-A1 HISTONE DEMETHYLASE INHIBITORS AND METHODS FOR USING THE SAME The Regents of the University of Colorado, a body corporated (US) 2013-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137720-A1 HISTONE DEMETHYLASE INHIBITORS AND METHODS FOR USING THE SAME KDM1A, KDM3A, KDM7A KDM6B 15/4885KDM4A 9/4885KDM2A 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.